Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire
Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from the markets.
Comments 0
Log in to join the conversation.
No comments yet. Be the first to share your thoughts!